Eon and LifePoint Health announced they have entered into a five-year agreement to develop the ‘Healthy Person Program.’ The new program pairs evidence-based follow-up with a first-of-its kind approach to identifying and tracking patients with incidentally found abnormal findings. It will allow for earlier diagnosis and treatment of potentially catastrophic diseases. This new collaboration between Eon and LifePoint extends a partnership that began in 2018 when LifePoint began using Eon technology and services to improve screening for lung cancer, the leading cause of cancer deaths in the U.S. The “Healthy Lung Program” leverages Eon’s Essential Patient Management (EPM) platform to identify and track patients at risk for lung cancer. LifePoint piloted this program in three of its communities to explore its effectiveness, eventually expanding it to all 88 of its hospital campuses across the nation. In addition to lung cancer screening for an eligible high-risk patient population, the Healthy Lung Program identifies incidental abnormal lung findings on X-ray, CT scans, and MRI reports that may be ordered for patients for clinical reasons other than the concern of potential lung cancer. If an abnormality is found, Eon EPM tracks the patient until they either clear the program and no longer need to be followed, or their findings change and they need further diagnostic intervention. This has resulted in earlier stage diagnosis of lung cancer, which can significantly increase the treatability of the disease—and patients’ chances of survival. Eon is the market leader for early detection of lung cancer and recently launched similar applications to identify and track additional disease states, including thyroid, pancreas, and aortic aneurysms among others. Using Computational Linguistics, a discipline of Artificial Intelligence (AI), Eon extracts abnormal findings and clinically relevant information from radiology reports and automates redundant and burdensome tasks for low-risk patients, while triaging high-risk patients for provider review. The result is more patients being captured within the system and longitudinally tracked per evidence-based guidelines. The Healthy Person Program is based on leading clinical practices and is designed to ensure timely notification of findings to providers and patients, improve patient follow up regarding findings, and ultimately lead to earlier detection of several diseases in the communities LifePoint serves. Eon and LifePoint anticipate rolling out the program in 2021 first by expanding to the identification of aortic aneurysms, and then by expanding to programs focused on detection and disease management of thyroid, pancreatic and breast cancers.